cheerleader wrote:For false claims and overstatement of effectiveness in advertising and unsubstatiated benefits to patients, and for understating side effects and risks.
Apparently the "happy people with MS" we see in those glossy brochures are not allowed.
Anecdotal evidence which is unsupported by research is against the law.
As Euphoniaa pointed out, I posted the Copaxone letter on that forum but am wondering how I missed Biogen's (my favorite company!!) warning letter
Must be slipping in my old age!
While these letters are more severe than ones I have read in the past, they are not new in the MS drug marketing wars. These companies know very well they are breaking FDA guidelines but as their sales reps have been known to say, "it's part of doing business." Stealing a few percent of the MS patient market away from your competitor can mean millions of dollars of additional revenue. To them, getting a slap on the wrist or kick in the butt for false advertising information is worth it.
The real damage here is to the new MS patients who may see this and think that by taking these drugs, all will be well. We know differently and so will these new patients who eventually will discover that the information they read was nothing but slick marketing.
Unfortunately, I have seen this "game" going on for many years now and is one of many reasons why I detest the CRABs and the companies that make them. But as some people have said in the past, I must have an agenda and am a negative person!!